Ambulance station that has been closed for years set for refurbishment
However the Welsh Ambulance Service has said a refurbished station in Monmouth could be completed by end of the March 2026.
Crews have operated from a temporary building since the closure of the town's ambulance station some 13 years ago when it was 'sadly, condemned as not fit for purpose,' according to Councillor Martin Newell.
The Conservative member for the Town ward said paramedics and crews now operate from what he called 'a Portakabin' and said 'winter is coming and it is draughty and it leaks.'
He asked if Monmouthshire County Council's cabinet member Ian Chandler, whose role also includes health, could provide an update on any discussions over a new ambulance station with the service.
Cllr Chandler said the service had signed off on plans to rebuild the station in November last year, and the county council's planning department had offered pre-application advice, but it has since decided on a refurbishment instead.
The Green Party councillor said: 'The Welsh Ambulance Service NHS Trust has now assessed the options and decided to press head with a refurbishment of the existing building they tell me they are scoping out what they can do with the internal structure and a final design to be to be signed off and go out for tender.'
Cllr Chandler said the service has said its project board is 'very supportive of the refurbishment option and it hopefully means work can begin in early autumn and be completed by the end of the financial year but that could be subject to change due to a range of factors.'
Cllr Chandler promised to keep councillors updated and added: 'In my view it's very positive news we will have a refurbished and fully functioning ambulance station within the next nine months.'
Mitchell Troy and Trellech councillor Richard John, the leader of the Conservative group, said the ambulance service had initially considered a joint emergency services base with the fire service, which has a station next door to the ambulance station on Rockfield Road, and police but that plan was abandoned on cost grounds.
Cllr John, writing on social media, said while it was 'disappointing' the revised plans for a standalone ambulance station had also been dropped he welcomed the 'scaled back proposals' as 'infinitely better than current conditions' as he said in the temporary building crews have been left without running water during the winter.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Mounjaro weight loss injection: List of people who qualify and how it works
The mass rollout of weight loss injections on the NHS in England began in June. It means GPs are allowed to prescribe the drugs for the first time. Around 220,000 people are expected to receive Mounjaro, also known as tirzepatide. The drug is an antidiabetic drug which lowers blood sugar levels and and slows down how quickly food is digested. Mounjaro will be prescribed to severely overweight people who also suffer from a range of other health problems. It will be made by Lilly, through the NHS over the next three years. In the first year of the programme, the drug will be offered to people with a body mass index (BMI) score of over 40 who have at least four other health problems linked to obesity, such as type 2 diabetes, high blood pressure, heart disease and obstructive sleep apnoea. READ MORE: New 'Frankenstein' Covid 'Stratus' strain 'soaring in UK' has one unique symptom READ MORE: Crime boss' wife 'forced to live in a tent' when their illegal scrap yard is closed down Dr Claire Fuller, from NHS England, said: 'This is an important next step in the rollout of weight loss drugs, with community-based services now able to offer this treatment from today. 'We urgently need to address rising levels of obesity and prioritise support for those who are experiencing severe ill health – and greater access to weight loss drugs will make a significant difference to the lives of those people. 'These drugs are an important tool alongside the range of wraparound NHS support and advice on good nutrition and increasing physical activity, which will be vital in helping some people lose weight and reduce their risk of serious long-term conditions. 'While not everyone will be eligible for weight loss drugs, it's important that anyone who is worried about the impact of their weight on their health discusses the range of NHS support available with their healthcare professional.' National Institute for Health and Care Excellence (NICE) recommends tirzepatide (Mounjaro) for the management of obesity for certain patients. Tirzepatide comes in the form of an injection which you inject yourself, once a week. Your doctor or nurse will show you how to use it. Before prescribing tirzepatide, a healthcare professional will talk through the benefits and limitations, including any side effects you might get. If a drug prescribed for weight loss is recommended, you will need to eat a balanced, reduced calorie diet and take part in physical activity regularly whilst taking the medicine. It is not recommended if you are pregnant or planning to get pregnant, breastfeeding, or if you have certain health conditions. For those taking the contraceptive pill and using tirzepatide, the NHS recommends using an additional method of contraception, such as a condom, for the first four weeks of treatment and for four weeks after each dose increase as the contraceptive pill may not be absorbed by the body during this time. Potential side effects of tirzepatide include nausea, vomiting, diarrhoea and constipation, according to the National Institute for Health and Care Excellence. Estimates suggest around 1.5 million people in the UK are already taking weight loss drugs, which may have been prescribed through specialist weight loss services or via private prescription. Health Secretary Wes Streeting said: 'Obesity is now one of the leading causes of ill health, costing the NHS billions. Yet we now have the science, technology, and knowledge to end the obesity epidemic, if we seize this opportunity. 'Obesity jabs are used by 1.5 million people in the UK, mainly through private prescriptions. The NHS was founded on a promise to 'universalise the best', and this Government is determined to bring revolutionary modern treatments to everyone who needs them, not just those who can afford to pay. 'This rollout is an important step in making these medicines more widely available, and beginning to shift the focus of healthcare from sickness to prevention, which our forthcoming 10-year plan will deliver.'
Yahoo
2 hours ago
- Yahoo
Young Scottish woman's holiday nightmare after 'sun cream mix up'
A Scottish dancer's face swelled up so much she could barely see after she used tanning oil instead of sun cream. Hally Galletta was making the most of the UK heatwave at an outdoor swimming pool. The 23-year-old forgot her own sun cream and instead applied some of her friend's tanning oil, assuming it had SPF in it. And after four hours in 32C (89F) heat, her face had turned bright red. Hally's face started to swell, and the next morning she was in agony and could barely open her eyes. READ MORE: Ryanair flight 'utter chaos' as passengers 'jump off wing' with 18 people injured READ MORE: Edinburgh man was 'spending £400 a month on takeaways' before going on Mounjaro READ MORE - Oasis fans say gig-goer 'didn't deserve' ticket as they spot what she's doing READ MORE - Alan Titchmarsh makes 'heartbreaking' find after returning home with wife "It was a hot day - 32C with a UV index of eight," Hally, from Perth, told What's the Jam. I normally wear SPF every single day, but that morning I forgot to put it on. "I knew my friend was bringing tanning oil and I used that, not realising it didn't have any SPF in it. I was only in the sun for about four hours. "When we left the pool, my face was red, but I didn't think too much of it because I'd never had a bad sunburn before. "Later that evening, it started to swell. I put on some aftersun and hoped it would be better by morning, but when I woke up, I could barely open my left eye, and the pain was awful. "I kept trying to manage it at home with aloe vera, antihistamines, ibuprofen and ice, but nothing helped. The next day, my skin felt even tighter, more painful, and then it started to blister and peel." Join Edinburgh Live's Whatsapp Community here and get the latest news sent straight to your messages. Hally says her face was so red and swollen that people were staring at her in the street. Her face is still recovering, and Hally worries there will be long-term damage to her skin. She said, "It was really noticeable. People were staring when I was out, and when I went to work, everyone was asking if I needed to go home or see a doctor. "My friends and family were really concerned. My face is still healing. It's peeling and sore, and I'm planning to see a doctor soon to check everything is okay and that there's no long-term damage." Hally is sharing her story to raise awareness of the importance of wearing sun cream. She added, "It's been such a wake-up call. I think a lot of people my age still think more about getting a tan than protecting their skin, but I'll never leave the house without SPF 50 on my face again. "It's really not worth the pain or the risk. I'm just praying my face goes back to normal soon."
Yahoo
3 hours ago
- Yahoo
Weedkiller ingredient widely used in US can damage organs and gut bacteria, research shows
The herbicide ingredient used to replace glyphosate in Roundup and other weedkiller products can kill gut bacteria and damage organs in multiple ways, new research shows. The ingredient, diquat, is widely employed in the US as a weedkiller in vineyards and orchards, and is increasingly sprayed elsewhere as the use of controversial herbicide substances such as glyphosate and paraquat drops in the US. But the new piece of data suggests diquat is more toxic than glyphosate, and the substance is banned over its risks in the UK, EU, China and many other countries. Still, the EPA has resisted calls for a ban, and Roundup formulas with the ingredient hit the shelves last year. Related: 'We thought we'd got the numbers wrong': how a pristine lake came to have the highest levels of 'forever chemicals' on record 'From a human health perspective, this stuff is quite a bit nastier than glyphosate so we're seeing a regrettable substitution, and the ineffective regulatory structure is allowing it,' said Nathan Donley, science director with the Center For Biological Diversity, which advocates for stricter pesticide regulations but was not involved in the new research. 'Regrettable substitution' is a scientific term used to describe the replacement of a toxic substance in a consumer product with an ingredient that is also toxic. Diquat is also thought to be a neurotoxin, carcinogen and linked to Parkinson's disease. An October analysis of EPA data by the Friends of the Earth non-profit found it is about 200 times more toxic than glyphosate in terms of chronic exposure. Bayer, which makes Roundup, faced nearly 175,000 lawsuits alleging that the product's users were harmed by the product. Bayer, which bought Monsanto in 2018, reformulated Roundup after the International Agency for Research on Cancer classified glyphosate as a possible carcinogen. The new review of scientific literature in part focuses on the multiple ways in which diquat damages organs and gut bacteria, including by reducing the level of proteins that are key pieces of the gut lining. The weakening can allow toxins and pathogens to move from the stomach into the bloodstream, and trigger inflammation in the intestines and throughout the body. Meanwhile, diquat can inhibit the production of beneficial bacteria that maintain the gut lining. Damage to the lining also inhibits the absorption of nutrients and energy metabolism, the authors said. The research further scrutinizes how the substance harms the kidneys, lungs and liver. Diquat 'causes irreversible structural and functional damage to the kidneys' because it can destroy kidney cells' membranes and interfere with cell signals. The effects on the liver are similar, and the ingredient causes the production of proteins that inflame the organ. Meanwhile, it seems to attack the lungs by triggering inflammation that damages the organ's tissue. More broadly, the inflammation caused by diquat may cause multiple organ dysfunction syndrome, a scenario in which organ systems begin to fail. The authors note that many of the studies are on rodents and more research on low, long-term exposure is needed. Bayer did not immediately respond to a request for comment. Despite the risks amid a rise in diquat's use, the EPA is not reviewing the chemical, and even non-profits that push for tighter pesticide regulations have largely focused their attention elsewhere. Donley said that was in part because US pesticide regulations are so weak that advocates are tied up with battles over ingredients like glyphosate, paraquat and chlorpyrifos – substances that are banned elsewhere but still widely used here. Diquat is 'overshadowed' by those ingredients. 'Other countries have banned diquat, but in the US we're still fighting the fights that Europe won 20 years ago,' Donley said. 'It hasn't gotten to the radar of most groups and that really says a lot about the sad and sorry state of pesticides in the US.' Some advocates have accused the EPA of being captured by industry, and Donley said US pesticide laws were so weak that it was difficult for the agency to ban ingredients, even if the will exists. For example, the agency banned chlorpyrifos in 2022, but a court overturned the decision after industry sued. Moreover, the EPA's pesticides office seems to have a philosophy that states that toxic pesticides are a 'necessary evil', Donley said. 'When you approach an issue from that lens there's only so much you will do,' he said.
